# Data Extraction Form: Intervention Details

**Study ID**: [Auto-generated]
**Reviewer**: [Name]
**Extraction Date**: [Date]

## 1. Intervention Classification

**Primary Intervention Category**:
- [ ] Pre-authorization/prior approval
- [ ] Prospective audit and feedback (PAF)
- [ ] Rapid diagnostic pathways
- [ ] Computerized decision support (CDSS)/e-prescribing
- [ ] Education and guidelines
- [ ] Bundle interventions
- [ ] Combination interventions
- [ ] Other: ____________________________

**Intervention Components** (check all that apply):

### Pre-authorization
- [ ] Restricted formulary requiring approval
- [ ] ID physician approval required
- [ ] Pharmacist approval required
- [ ] Pre-defined criteria for approval
- [ ] Real-time approval process
- [ ] Other: ____________________________

### Prospective Audit and Feedback
- [ ] Daily review of prescriptions
- [ ] Non-formulary antibiotic review
- [ ] Prolonged duration review
- [ ] In-person feedback
- [ ] Electronic feedback
- [ ] Written recommendations
- [ ] Verbal recommendations
- [ ] Other: ____________________________

### Rapid Diagnostic Pathways
- [ ] PCR-based diagnostics
- [ ] MALDI-TOF
- [ ] Microarray technology
- [ ] Biomarker testing
- [ ] Rapid susceptibility testing
- [ ] Point-of-care testing
- [ ] Other: ____________________________

### CDSS/e-Prescribing
- [ ] Electronic prescribing system
- [ ] Clinical decision support alerts
- [ ] Dose optimization algorithms
- [ ] Drug interaction checking
- [ ] Renal dosing adjustments
- [ ] Antibiotic time-outs
- [ ] Other: ____________________________

### Education and Guidelines
- [ ] Educational sessions for prescribers
- [ ] Printed guidelines
- [ ] Pocket cards
- [ ] Academic detailing
- [ ] Local consensus guidelines
- [ ] National guidelines adoption
- [ ] Other: ____________________________

## 2. Implementation Details

**Intervention Development**:
- [ ] Locally developed
- [ ] Based on national guidelines
- [ ] Based on international guidelines
- [ ] Hybrid approach

**Implementation Team**:
- [ ] Infectious diseases physician
- [ ] Clinical pharmacist
- [ ] Infection control specialist
- [ ] Microbiologist
- [ ] Information technology specialist
- [ ] Hospital administration
- [ ] Other: ____________________________

**Training and Education**:
- Duration of training: ____________________________ hours/days
- Training methods:
  - [ ] Lectures
  - [ ] Workshops
  - [ ] Online modules
  - [ ] One-on-one sessions
  - [ ] Other: ____________________________

## 3. Technology and Resources

**Technology Requirements**:
- Hardware: ____________________________
- Software: ____________________________
- Integration with EHR: [ ] Yes [ ] No

**Personnel Requirements**:
- Full-time equivalents (FTE):
  - ID physicians: ____________________________
  - Pharmacists: ____________________________
  - Other: ____________________________

**Financial Resources**:
- Implementation cost: ____________________________
- Annual operating cost: ____________________________
- Cost per patient: ____________________________

## 4. Intervention Intensity and Duration

**Frequency of Intervention**:
- [ ] Continuous (24/7)
- [ ] Business hours only
- [ ] Weekdays only
- [ ] Specific times: ____________________________

**Duration of Intervention**:
- [ ] One-time implementation
- [ ] Time-limited (specify: ____________________________)
- [ ] Ongoing/continuous

**Intervention Coverage**:
- [ ] All hospital wards
- [ ] Specific wards only: ____________________________
- [ ] ICU only
- [ ] Emergency department
- [ ] Other: ____________________________

## 5. Comparator Details

**Control/Usual Care Description**:
____________________________________________________________
____________________________________________________________
____________________________________________________________

**Standard Practices in Control**:
- [ ] No formal stewardship
- [ ] Basic infection control only
- [ ] Ad hoc consultations
- [ ] Other: ____________________________

## 6. Intervention Fidelity

**Monitoring of Implementation**:
- [ ] Process measures tracked
- [ ] Fidelity assessments conducted
- [ ] Regular audits performed
- [ ] Feedback loops established

**Barriers to Implementation** (reported):
____________________________________________________________
____________________________________________________________

**Facilitators of Success** (reported):
____________________________________________________________
____________________________________________________________

## 7. Contextual Factors

**Hospital Characteristics**:
- Teaching status: [ ] Yes [ ] No
- Trauma center: [ ] Yes [ ] No
- Transplant center: [ ] Yes [ ] No

**Patient Population**:
- Case mix index: ____________________________
- Average length of stay: ____________________________ days
- ICU occupancy rate: ____________________________ %

**Baseline Practices**:
- Existing stewardship elements: ____________________________
- Antibiotic control policies: ____________________________
- Infection control resources: ____________________________

## 8. Intervention Details by Study Arm

**Arm 1 (Reference)**:
- Intervention name: ____________________________
- Detailed description: ____________________________
- Duration: ____________________________
- Frequency: ____________________________

**Arm 2**:
- Intervention name: ____________________________
- Detailed description: ____________________________
- Duration: ____________________________
- Frequency: ____________________________

**Arm 3**:
- Intervention name: ____________________________
- Detailed description: ____________________________
- Duration: ____________________________
- Frequency: ____________________________

**Arm 4**:
- Intervention name: ____________________________
- Detailed description: ____________________________
- Duration: ____________________________
- Frequency: ____________________________

**Arm 5**:
- Intervention name: ____________________________
- Detailed description: ____________________________
- Duration: ____________________________
- Frequency: ____________________________

## 9. Notes and Clarifications

**Implementation Challenges**: ____________________________
____________________________________________________________

**Unique Features**: ____________________________
____________________________________________________________

**Additional Resources**: ____________________________
____________________________________________________________

---

**Extraction Verification**:
- [ ] All intervention components identified
- [ ] Implementation details complete
- [ ] Comparator adequately described
- [ ] Second reviewer verification completed
